scholarly journals Effect of zinc source and implant strategy on performance, carcass characteristics, and trace mineral concentrations in finishing feedlot steers

Author(s):  
Elizabeth M Messersmith ◽  
Stephanie L Hansen

Abstract Seventy-two Angus-crossbred steers (411 ± 16 kg) were assigned to a 2 × 3 factorial arrangement of treatments to examine the effects of blended Zn source supplementation on performance, carcass characteristics, and trace mineral parameters of steers administered no implant or a two-implant program. Factors included implant (IMP) strategies and Zn supplementation. During the 126-d study steers were either not implanted (NoIMP) or implanted (IS/200; Elanco, Greenfield, IN) on d 0 (Component TE-IS; 80 mg trenbolone acetate + 16 mg estradiol) and 57 (Component TE-200; 200 mg trenbolone acetate + 20 mg estradiol). All steers were fed 70 mg Zn/kg on a dry matter (DM) basis from ZnSO4 + 30 mg Zn/kg DM from either basic ZnCl (Vistore Zn, Phibro Animal Health, Teaneck, NJ), Zn glycinate (Gemstone Zn, Phibro Animal Health), or ZnSO4 (ZnB, ZnG, or ZnS, respectively). Steers were blocked by weight into pens of 6 and fed a dry rolled corn-based diet via GrowSafe bunks (GrowSafe Systems Ltd.; Airdrie, AB, Canada). Data were analyzed using the Mixed Procedure of SAS, with fixed effects of Zn, IMP, and the interaction. Steer was the experimental unit (n = 12 steers/treatment). Liver and muscle collected on d -5, 14, 71, and 120 were analyzed for Zn concentration, and data were analyzed as repeated measures (repeated effect = Day). An IMP × Zn tendency (P = 0.07) was observed for d 126 body weight with no effects of Zn within NoIMP while ZnS tended to be heavier than ZnB with ZnG intermediate within IS/200. Carcass-adjusted overall feed efficiency (G:F) was greatest for ZnS (Zn; P = 0.02). Implanted cattle had greater DM intake, G:F, and carcass-adjusted performance (P ≤ 0.01). Liver Zn concentrations were greater for IS/200 by d 120 (IMP × Day; P = 0.02). Within IS/200, ZnG tended to have greater muscle Zn than ZnS while ZnB was intermediate (Zn × IMP; P = 0.09). No Zn or IMP × Zn (P ≥ 0.12) effects were observed for carcass data. However, IS/200 had greater hot carcass weight, dressing percentage, and ribeye area than NoIMP (P ≤ 0.001). These data suggest implants improve growth and influence Zn metabolism. Future work should examine Zn sources and supplementation alongside implant strategies.

2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 159-159
Author(s):  
Elizabeth M Messersmith ◽  
Angela Boyer ◽  
Dennis Nuzback ◽  
Stephanie L Hansen

Abstract A 126-d study utilized 72 Angus-cross steers (411 ± 16 kg) in a 3 × 2 factorial to examine the effects of Zn source and implant strategy on performance, carcass characteristics, and tissue Zn concentrations. All steers received 70 mg Zn/kg dry matter (DM) from ZnSO4 + 30 mg Zn/kg DM from one of three sources: zinc hydroxychloride (ZnHC), zinc glycinate (ZnG), or zinc sulfate (ZnS). Implant (IMP) strategies included: no implant (NoIMP) or Component TE-IS and Component TE-200 (IS/200) on d 0 and 57, respectively. Steers were blocked by weight into pens of 6 and fed a dry rolled corn-based diet via GrowSafe bunks. Data were analyzed using ProcMixed of SAS, with fixed effects of Zn, IMP, and the interaction. Liver and muscle collected on d -5, 14, 71, and 120 were analyzed for Zn concentration and data were analyzed as repeated measures (repeated effect = day). Steer was the experimental unit (n = 12/treatment). Final body weight and overall average daily gain tended to be decreased for ZnHC compared to ZnS, with ZnG intermediate within IS/200 (Zn × IMP; P ≤ 0.07). No interaction was observed for overall G:F or DM intake (P ≥ 0.41), but both were greater for implanted steers (P ≤ 0.01), while overall G:F was improved for ZnS compared to ZnHC and ZnG (P = 0.02). Carcass characteristics were unaffected by Zn × IMP or Zn source (P ≥ 0.12), but IS/200 improved HCW, DP, and REA (P ≤ 0.01). Implant increased liver Zn (P = 0.02) concentrations. Within IS/200 ZnG tended to have greater muscle Zn than ZnS while ZnHC was intermediate (Zn × IMP; P = 0.09), potentially indicating differences in availability of Zn source to growing muscle. These data suggest Zn source and implant influence performance and tissue Zn concentrations.


2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 154-155
Author(s):  
Elizabeth M Messersmith ◽  
Caleb C Reichhardt ◽  
Kara J Thornton ◽  
Stephanie L Hansen

Abstract Forty-eight commercial Angus steers (327 ± 25 kg) were utilized to determine effects of varying implant hormone composition on liver and plasma trace mineral concentrations. Implant (IMP) treatments (n = 12/treatment) included: no implant (CON), estradiol (E2; Compudose; 25.7 mg estradiol; Elanco Animal Health; Greenfield, IN), trenbolone acetate (TBA; Finaplix H; 200 mg trenbolone acetate; Merck Animal Health; Madison, NJ), and a combination of estradiol and trenbolone acetate (ETBA Revalor-S; 24 mg estradiol + 120 mg trenbolone acetate; Merck Animal Health). Cattle were fed forage-based step up rations throughout the sampling period. Plasma samples were collected on d 0, 2, 10 and 30, with liver biopsies collected on d 2 and 10. Data were analyzed with ProcMixed of SAS with fixed effect of IMP. Contrast statements for each treatment vs CON were developed. Plasma trace mineral analysis utilized repeated measures (repeated effect = day). No IMP × Day effects (P ≥ 0.18) on plasma trace mineral were observed. Day 2 liver Zn and Cu and d 10 liver Mn were lesser (P ≤ 0.04) for TBA implanted steers than CON and d 2 liver Mn tended to be lesser (P = 0.06). The Mn response may reflect changes in protein metabolism due to TBA. However, E2 and ETBA tended to have greater (P ≤ 0.07) d 10 liver Fe concentrations than CON while plasma Fe was unaffected (P ≥ 0.75) by E2, TBA, or ETBA. Both d 2 liver and plasma Zn were lesser for ETBA than CON (P ≤ 0.04) likely driven by the TBA in the implant. Implant contrasts did not affect (P ≥ 0.13) other plasma or liver trace mineral concentrations. These data indicate implant strategies, and thus hormones differentially influence trace mineral metabolism in feedlot steers, which may have implications for diet formulation.


Animals ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 1964
Author(s):  
Caleb C. Reichhardt ◽  
Elizabeth M. Messersmith ◽  
Tevan J. Brady ◽  
Laura A. Motsinger ◽  
Reganne K. Briggs ◽  
...  

Fifty Angus-sired steers were utilized to evaluate the effects of anabolic implants varying in hormone type and concentration on performance, carcass traits, and plasma and liver trace mineral concentrations over 129 d. Steers were stratified by weight into one of four (n = 12 or 13/treatment) implant treatments: (1) estradiol (E2; 25.7 mg E2; Compudose, Elanco Animal Health, Greenfield, IN, USA), (2) trenbolone acetate (TBA; 200 mg TBA; Finaplix-H, Merck Animal Health, Madison, NJ, USA), (3) combination implant (ETBA; 120 mg TBA + 24 mg E2; Revalor-S, Merck Animal Health), or (4) no implant (CON). Steers were randomly assigned to pens equipped with GrowSafe bunks and fed a corn and barley-based finishing ration. Overall average daily gain and body weight were greater for ETBA and TBA than CON (p ≤ 0.04), but not E2 (p ≥ 0.12). Feed efficiency and hot carcass weight were only greater than CON for ETBA (p ≤ 0.03). Plasma and d 2 liver Zn concentrations were lesser for ETBA than CON (p ≤ 0.01) and d 10 liver Mn was lesser (p = 0.0003) for TBA than CON. These data indicate that implants containing TBA influence growth and trace mineral parameters, though more work investigating this relationship is necessary.


2019 ◽  
Vol 97 (Supplement_2) ◽  
pp. 129-130
Author(s):  
Elizabeth Schumacher ◽  
Galen E Erickson ◽  
D J Jordon ◽  
Robert Cooper ◽  
Tony Scott ◽  
...  

Abstract A commercial feedyard study utilizing crossbred heifers (n = 1,737; initial BW 313 kg) fed for 182 days compared the effect of two implant strategies on performance and carcass characteristics. The study design was a randomized complete block with block as arrival date and initial BW; with pen as the experimental unit (12/treatment). Heifers were implanted with Synovex ONE Feedlot [200 mg trenbolone acetate (TBA), 28 mg estradiol benzoate (EB)] on d 1 (ONE), or implanted with Synovex Choice (100 mg TBA, 14 mg EB) on d 1 followed by Synovex Plus (200 mg TBA, 28 mg EB) on d 95 (CH/Plus). Statistical analysis was conducted using the Mixed procedure of SAS with treatment and block considered fixed effects for performance. Quality grade (QG) and yield grade (YG) data were analyzed using the GLIMMIX procedure of SAS. Implanting with Ch/PLUS tended to improve ADG and HCW (P ≤ 0.13) compared to implanting with ONE. Heifers implanted using ONE tended (P = 0.09) to have greater DMI than CH/PLUS heifers. Intakes were similar (P = 0.34) between treatments before re-implanting, but CH/Plus heifers had lower (P < 0.01) DMI in the final 85 days. Heifers implanted using CH/PLUS had significantly (P < 0.01) greater G:F calculated on a carcass basis compared to heifers implanted with ONE. Heifers implanted with CH/PLUS had significantly (P ≤ 0.02) lower marbling score and YG, higher dressing percentage, and greater LM area compared to heifers implanted with ONE. Heifers implanted with ONE tended to have improved QG distribution (P = 0.06) but poorer YG distribution (P = 0.09) compared to heifers implanted using CH/PLUS. These data suggest that implanting heifers with Synovex ONE Feedlot resulted in slightly less efficiency but better quality grade when fed equal days compared with using Synovex Choice and Plus reimplant program.


2020 ◽  
Vol 4 (4) ◽  
Author(s):  
Dalton Humphrey ◽  
Spenser Becker ◽  
Jason Lee ◽  
Keith Haydon ◽  
Laura Greiner

Abstract Four hundred and eighty (PIC 337 X 1050, PIC Genus, Hendersonville, TN) pigs were used to evaluate a novel threonine source (ThrPro, CJ America Bio, Fort Dodge, IA) for nursery pigs from approximately 7 to 20 kg body weight (BW). After weaning, pigs were sorted by sex and fed a common diet for 1 wk. Upon completion of the first week, pigs were sorted into randomized complete blocks, equalized by weight, within 16 replications. Pigs were allocated to one of three dietary treatments: positive control (POS)—standard ileal digestible threonine-to-lysine ratio (SID; Thr:Lys) 0.60, negative control (NEG)—SID Thr:Lys ≤0.46, and alternative Thr source (TEST)—SID Thr:Lys 0.60. The alternative Thr source included fermentative biomass and was assumed to contain 75% Thr and a digestibility coefficient of 100% based on the manufacturer’s specifications. All other nutrients met or exceeded the NRC recommendations. Growth and intake data were analyzed as repeated measures with a compound symmetry covariance structure using the MIXED procedure in SAS 9.4 (SAS Institute Inc., Cary, NC) with pen as the experimental unit. Treatment, phase, the interaction between treatment and phase, and block were included as fixed effects in the model. Differences in total removals were tested using Fisher’s Exact Test of PROC FREQ. Results were considered significant at P ≤ 0.05 and considered a trend at P &gt; 0.05 and P ≤ 0.10. During the first 14 d, pigs fed TEST had decreased gain-to-feed ratio (G:F; 0.77 vs. 0.80, P = 0.022) compared to POS and increased G:F (0.77 vs. 0.73, P &lt; 0.001) compared to NEG. Over days 14–28, pigs fed TEST had similar G:F (0.71 vs. 0.70, P = 0.112) compared to POS and increased G:F (0.71 vs. 0.63, P &lt; 0.001) compared to NEG. Overall (days 0–28), pigs fed TEST had similar average daily gain (ADG; 0.47 vs. 0.47 kg/d, P = 0.982) and G:F (0.76 vs. 0.74, P = 0.395) compared to POS and increased ADG (0.47 vs. 0.43 kg/d, P &lt; 0.001) and G:F (0.76 vs. 0.67, P &lt; 0.001) compared to NEG. The average daily feed intake was not significantly different across treatments for the entirety of the study. In conclusion, the replacement of crystalline L-Thr with a novel Thr source resulted in similar growth performance in nursery pigs from approximately 7 to 20 kg.


2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 152-153
Author(s):  
Aubree M Beenken ◽  
Erin L Deters ◽  
Colten W Dornbach ◽  
Stephanie L Hansen ◽  
Joshua C McCann ◽  
...  

Abstract Ninety-one early-weaned (65 ± 11 d) Angus steers (92 ± 4 kg) were blocked by age to a 2 × 2 factorial examining effects of injectable vitamin C (VC) at weaning and/or prior to transport to the feedlot on antibody titers and growth performance. Injections (20 mL/steer) of VC (250 mg sodium ascorbate/mL) or saline (SAL) were given at time of weaning on d 0 (WEAN) and/or prior to a 6 hr trucking event to a feedlot on d 49 (TRANS). Steers were given booster vaccinations on d 0. Steers were weighed on d 0, 1, 14, 48, 49, 64, 106, and 107. Blood was collected (12 steers/treatment) on d 0, 1, 2, 14, 49 (pre- and post-transit), 50, and 51. Data were analyzed via Proc-Mixed of SAS (experimental unit = steer; n = 22–23/treatment) with fixed effects of block, WEAN, TRANS, and WEAN × TRANS. Plasma ascorbate concentrations for weaning (d 0, 1, and 2) and transit (d 49-pre-trucking, 49-post-trucking, 50, and 51) were analyzed as repeated measures (repeated effect = day). Plasma ascorbate concentrations were greater on d 1 and 2 for steers that received VC at weaning (VC = 19.6, SAL = 8.8 ± 1.26 µM; WEAN × day P &lt; 0.01). Similarly, ascorbate concentrations were greater on d 49 post-trucking, 50, and 51 for steers that received VC pre-transit (TRANS × day P = 0.01). Treatments did not affect bodyweight or average daily gain throughout the trial (P &gt; 0.32). There were no effects of treatment on serum Bovine Viral Diarrhea Virus type 2 antibody titers on d 14 or 51 (P &gt; 0.33). An injection of VC administered to early weaned beef steers at weaning or pre-transit increases plasma ascorbate concentrations but does not improve growth performance or antibody response to vaccination booster.


2020 ◽  
Vol 4 (4) ◽  
Author(s):  
Pedro H V Carvalho ◽  
Mariana F Westphalen ◽  
Jonathan A Campbell ◽  
Tara L Felix

Abstract The objectives of the study were to determine the effect of coated or noncoated hormone implants on growth performance, carcass characteristics, and serum estradiol-17β (E2) concentrations of Holstein steers fed a grain-based diet for 112 d. Seventy-nine Holstein steers [average initial body weight (BW) = 452 ± 5.5 kg] were stratified by BW and allotted to one of two treatments: 1) Holstein steers implanted with a coated implant containing 200 mg of trenbolone acetate (TBA) and 40 mg E2 (Revalor-XS (Merck Animal Health; Summit, NJ)] on day 0 (XS) or 2) Holstein steers implanted two times (days 0 and 56) with a noncoated implant containing 80 mg of TBA and 16 mg of E2 [(2IS) Revalor-IS (Merck Animal Health)]. Data were analyzed using the MIXED procedure of SAS (SAS Inst. Inc., Cary, NC). There was no effect (P ≥ 0.71) of implant strategy on initial, middle, and final BW. No effect (P ≥ 0.12) of implant strategy was observed on average daily gain, dry matter intake, or gain-to-feed ratio. There were no effects (P ≥ 0.11) of implant strategy on carcass characteristics. There was an implant × day interaction (P &lt; 0.01) for the circulation of serum E2 concentrations. Serum E2 concentration increased similarly 14 d after Holstein steers were implanted, regardless of implant strategy. At 28 d, after steers were implanted, steers in the XS group had less serum E2 concentration than Holstein steers in the 2IS group. However, at 56 d after the first implantation, both groups, once again, had similar serum E2 concentrations and E2 concentrations were less on day 56 than day 28 for both strategies. Holstein steers implanted with 2IS had greater serum E2 concentration on day 70 and E2 concentrations remained greater than serum E2 of Holstein steers implanted XS for the duration of the trial (day 112). In summary, there was no effect of coated or two doses of noncoated implant on growth performance or carcass characteristics of Holstein steers.


2021 ◽  
Vol 99 (Supplement_3) ◽  
pp. 166-167
Author(s):  
Andrea M Osorio ◽  
Kaue T Tonelli Nardi ◽  
Igor Gomes Fávero ◽  
Kaliu G Scaranto Silva ◽  
Kymberly D Coello ◽  
...  

Abstract The effects of a nutritional packet were evaluated on CH4 emissions and apparent total tract nutrient digestibility of feedlot beef steers. Thirty Angus-crossbred steers (BW = 542 ± 8.4 kg) were used in a randomized complete block design and allocated into pens equipped with SmartFeed (C-Lock; 15 steers/treatment). Steers were consuming a steam-flaked corn-based diet (88% concentrate DM basis) ad libitum for the last 65 d on feed, and received the following treatments: 1) control and 2) a nutritional packet [0.29% DM basis; live yeast (Saccharomyces cerevisiae; 8.7 Log CFU/g); Vitamin C (5.4 g/kg); Vitamin B1 (13.33 g/kg); NaCl (80 g/kg); KCl (80 g/kg)]. Methane emissions and apparent total tract nutrient digestibility were measured during 3 periods with 5-d of collections each. Gas emissions from steers were measured utilizing the SF6 tracer technique. Feed and fecal samples were collected once and twice (0700 h and 1600 h) daily, respectively, to determine digestibility of nutrients using iNDF as an internal marker. Steer was considered the experimental unit. Data were analyzed as repeated measures using the MIXED procedure of SAS with the fixed effects of treatment, period, and their interaction, and the random effect of block. No treatment × period interactions (P ≥ 0.125) were observed for DMI and any of the CH4 production variables (g/day, g/kg BW0.75, g/nutrient intake, and g/nutrient digested). Moreover, treatments did not affect digestibility of DM, OM, or ADF (P ≥ 0.300); however, digestibility of NDF was increased for treated cattle (P = 0.013), which resulted in a tendency (P = 0.098) to decrease CH4 production in g per kg NDF intake and decreased (P = 0.020) grams CH4 per kg NDF digested. The nutritional packet may be altering ruminal fermentation on intensively managed steers and improving fiber digestibility, which can have benefits on CH4 emission intensity.


2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 80-81
Author(s):  
Cierrah J Kassetas ◽  
Joel Caton ◽  
James D Kirsch ◽  
Sheri T Dorsam ◽  
Kacie L McCarthy ◽  
...  

Abstract Thirty-six half-sibling yearling Angus bulls [256 ± 8 d; initial BW = 320 ± 2 kg] were assigned one of three diets: 1) 60% concentrate as corn (CON; n = 12); 2) 60% DDGS (60DDGS; n = 12); 3) CON diet + equivalent sulfur of 60DDGS as CaSO4 (SULF; n = 12) to evaluate effects of feeding 60% DDGS or sulfur as CaSO4 on trace mineral (TM) concentrations in serum and seminal plasma. Bulls were fed in Calan gates for 112 days and targeted to gain 1.6 kg/d. Data were analyzed as repeated measures using PROC MIXED in SAS. In serum, treatment × day interactions were observed (P ≤ 0.03) for Cu, Se, and Mo. For Cu, no differences (P &gt; 0.15) were observed at d 0 or 56, but at d 112, 60DDGS was reduced (P &lt; 0.01) compared with SULF and CON. At d 0, no differences (P &gt; 0.09) were observed for Se; however, at d 56 and 112, 60DDGS was greater (P &lt; 0.01) than CON and SULF. For Mo, at d 0, 60DDGS was greater (P = 0.03) than CON, whereas SULF was intermediate, but at d 56 and 112, CON was greater (P &lt; 0.01) than SULF and 60DDGS. In seminal plasma, treatment × day interactions were observed (P ≤ 0.02) for Cu and Mo. For Cu, no differences (P ≥ 0.09) were observed at d 0 or 56, but at d 112, CON and 60DDGS were greater (P &lt; 0.01) compared with SULF. For Mo, at d 0, 60DDGS was greater (P = 0.03) than SULF, whereas CON was intermediate, but on d 56 and 112, CON was greater (P &lt; 0.01) than 60DDGS and SULF. Differences observed for TM may have influenced enzyme activity and semen kinematics which were previously reported.


2019 ◽  
Vol 4 (1) ◽  
pp. 206-213 ◽  
Author(s):  
Pedro Henrique Vilela Carvalho ◽  
George A Perry ◽  
Tara L Felix

Abstract The objectives of the study were to determine the effect of steroidal implants on growth performance, carcass characteristics, and estradiol-17β (E2) concentrations in the blood and longissimus muscle of Holstein steers fed a grain-based diet. Seventy Holstein steers (average initial BW = 275 ± 6.4 kg, 10 to 12 mo of age) were assigned to treatments: (i) implanted with 80 mg of trenbolone acetate (TBA) and 16 mg of E2 (Component TE-IS with Tylan; Elanco Animal Health, Greenfield, IN) at the start of the trial (day 0), and reimplanted with 120 mg of TBA and 24 mg of E2 (Component TE-S with Tylan; Elanco Animal Health) on day 84 of the experiment; or (ii) no implant. Implanted Holstein steers were heavier (P ≤ 0.01) than nonimplanted Holstein steers in the middle (day 84) and at the end of the experiment (day 186). Implanting Holstein steers increased (P &lt; 0.01) average daily gain (ADG) and dry matter intake (DMI) without affecting gain-to-feed ratio compared with nonimplanted animals. Carcasses from implanted Holstein steers had greater (P &lt; 0.01) hot carcass weight (HCW) and longissimus muscle (LM) area than carcasses from nonimplanted steers. Implanting did not affect (P ≥ 0.21) other carcass characteristics. There was an increase (P = 0.03) of 1.3 pg of E2/g of muscle in implanted Holstein steers compared with that from nonimplanted Holstein steers. There was an implant × day interaction (P &lt; 0.01) in serum E2 concentrations. Serum E2 concentrations were not altered in nonimplanted Holstein steers, whereas E2 concentration increased (P &lt; 0.01) after steers were implanted, regardless of implant characteristics. Serum E2 peaked at 28 days after the first implant and then rapidly declined after day 56. In summary, steroidal implants administered on days 0 and 84 increased DMI, ADG, HCW, and LM area in Holstein steers compared with nonimplanted steers due to increased serum E2 concentrations. However, these changes did not improve feed efficiency or other carcass characteristics.


Sign in / Sign up

Export Citation Format

Share Document